###begin article-title 0
N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 454 459 454 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
The tumor suppressor, p53, is a transcription factor which can modulate the transcription of a number of target genes that are involved in cell-cycle arrest and apoptosis. However, the apoptotic pathway mediated by p53 is not fully understood. Here, we showed that N-Myc downstream-regulated gene 2 (NDRG2) is a new target gene that is regulated by p53. NDRG2 mRNA and protein levels can be upregulated in a p53-dependent manner. The first intron of the NDRG2 gene contains a site that binds p53 directly and mediates wild-type p53-dependent transactivation. In addition, silencing of NDRG2 attenuates p53-mediated apoptosis, whereas overexpression of NDRG2 suppresses tumor cell growth, regardless of the presence or absence of p53. Our results indicate that NDRG2 is a novel p53-inducible target that is involved in the p53-mediated apoptosis pathway.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 369 372 369 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5">3&#8211;5</xref>
###xml 596 597 596 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 598 599 598 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 726 729 726 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6 B7 B8 B9">6&#8211;9</xref>
###xml 780 782 780 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
The p53 tumor suppressor has long been regarded as the most important factor for the maintenance of genome integrity (1). In response to cellular stresses, p53 can induce diverse biological responses, including cell-cycle arrest, DNA repair and apoptosis (2). Though it is widely accepted that apoptosis induction is essential to the tumor-suppressive activity of p53 (3-5), the complicated mechanism is not fully understood. Growing evidence has shown that p53 can induce apoptosis through its actions as a transcription factor by transactivating numerous target genes in the apoptotic pathway (1,2,4). Recently, reports have demonstrated that p53 exerts its pro-apoptotic effects through transcription-repressive functions (6-9) as well as transcription-independent activities (10), suggesting that p53 may utilize multiple pathways to initiate apoptotic signals.
###end p 5
###begin p 6
###xml 458 459 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 460 465 460 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11 B12 B13">11&#8211;13</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1146 1151 1146 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15 B16 B17 B18 B19 B20 B21">15&#8211;21</xref>
###xml 1385 1390 1385 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 1393 1398 1393 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22 B23 B24">22&#8211;24</xref>
###xml 1627 1629 1627 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1630 1632 1630 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
Under normal circumstances, p53 is maintained at low levels mainly via the action of murine double minute 2 (MDM2) E3 ubiquitin ligase, which directs p53 ubiquitination and degradation. Upon various stresses, such as hypoxia, heat shock, ionizing and UV light irradiation, treatment with chemotherapeutic agents and viral infection, p53 protein levels rise dramatically and are activated by posttranslational modifications to the protein itself and/or MDM2 (2,11-13). Activated p53 functions as a sequence-specific DNA-binding transcription factor and induces expression of its downstream target genes by recognizing a 20-bp response element, which is generally located in the promoter or intronic regions. The consensus sequence is 5'-PuPuPuC(A/T-A/T)GPyPyPy-N(0-13)-PuPuPuC(A/TA/T)GPyPyPy-3', and the fourth C and seventh G are highly conserved in the 10-bp half-sites (14). To date, more than a hundred p53 target genes have been identified (10), and some of these proteins are able to mediate p53-induced apoptosis. These proteins include molecules with a pro-apoptotic potential, such as BAX, NOXA, PUMA, BID, FAS/APO1, Pidd and KILLER/DR5 (15-21), as well as some newly identified proteins, which are not part of the canonical intrinsic and extrinsic apoptotic pathways, such as Scotin, voltage-gated sodium channel, type III, beta (SCN3B) and N-Myc downstream-regulated gene 1 (NDRG1) (22-24). Nevertheless, none of these downstream targets fully contribute to the p53-mediated apoptotic response, indicating that p53 may activate a subset of apoptosis-related genes in a cell context- or stress type-dependent fashion (10,25).
###end p 6
###begin p 7
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG</italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG3</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG4</italic>
###xml 327 332 327 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27 B28 B29">27&#8211;29</xref>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 549 554 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 662 667 662 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32 B33 B34">32&#8211;34</xref>
###xml 762 767 762 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35 B36 B37 B38">35&#8211;38</xref>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 929 934 929 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1107 1112 1107 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43 B44 B45 B46 B47 B48">43&#8211;48</xref>
###xml 1247 1253 1247 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1255 1257 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1277 1282 1277 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 1432 1437 1432 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 119 124 <span type="species:ncbi:9606">human</span>
###xml 784 789 <span type="species:ncbi:9606">human</span>
Human NDRG2 (also named SYLD/KIAA1248) belongs to the NDRG family and was first cloned in our laboratory from a normal human brain cDNA library by subtractive hybridization (GenBank, Accession No. AF 159092) (26). This family consists of four members, NDRG1, NDRG2, NDRG3 and NDRG4, which share roughly 60% residue identities (27-29). The members have different tissue expression patterns, indicating that they may play distinct roles (27,28), but some exhibit similarities in either expression regulation or biological functions. For example, both NDRG1 and NDRG2 can be transcriptionally repressed by Myc (30,31) and upregulated by hypoxia and nickel reagent (32-34). Previous studies demonstrated that both proteins were involved in cellular differentiation (35-38) and in certain human nervous system disorders (39,40). Importantly, NDRG1 is well-documented to be associated with a tumor-suppression function (37,41,42), and NDRG2 was proposed to be a candidate tumor suppressor gene due to its reduced expression in many cancer tissues and its ability to inhibit proliferation in certain cancer cells (43-48). However, to date, the exact function of Ndrg2 in cellular processes, including carcinogenesis, is unclear. In a recent study, Stein et al. (24) demonstrated that NDRG1 acts as a necessary contributor during p53-induced caspase activation and apoptosis. This led us to question whether there is a relationship between NDRG2 and p53, which would help identify the biological function of Ndrg2 and better understand the p53-regulated cellular responses.
###end p 7
###begin p 8
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
In this study, we report that the NDRG2 gene is transcriptionally regulated by p53. NDRG2 mRNA and protein synthesis were induced by overexpressing p53 via either an adenovirus infection or stabilization of p53 after DNA damage. Analysis of the NDRG2 genomic loci revealed one potential p53-binding element in intron 1, which was verified as a functional p53 response element that specifically binds to endogenous or exogenous p53. In addition, our experiments using RNA interference suggest that NDRG2 is involved in the p53-mediated apoptosis pathway.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Cell lines and cell culture
###end title 10
###begin p 11
###xml 560 561 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 416 422 <span type="species:ncbi:9913">bovine</span>
The human tumor cell lines H1299 (p53 null), Saos2 (p53 null), MDA-MB-231 (mutant p53), SK-BR-3 (mutant p53), A549 [wild-type (wt) p53], U87 (wt p53) and the human embryonic kidney cell line (HEK293) were obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen Life Technologies, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (FBS) (Sijiqing Biological Engineering Materials Co., Hangzhou, China). Cells were incubated at 37degreesC in the presence of 5% CO2-balanced air.
###end p 11
###begin title 12
Real-time PCR
###end title 12
###begin p 13
###xml 282 287 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Actin</italic>
###xml 427 431 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG</italic>
###xml 517 520 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 611 616 604 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">actin</italic>
###xml 699 703 692 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG</italic>
###xml 706 709 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p21</italic>
###xml 719 724 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">actin</italic>
Total RNA was extracted using TRIZOL reagent (Invitrogen) according to the manufacturer's protocol. Total RNA (2 mug) was reverse transcribed with reverse transcriptase (Promega, WI, USA). The first strand cDNA was used as the template for real-time quantitative PCR analysis. beta-Actin cDNA was used as an internal control to normalize variances. The following primers were designed using the ABI Primer Express software for NDRG2: 5'-GAGATATGCTCTTAACCACCCG-3' (forward) and 5'-GCTGCCCAATCCATCCAA-3' (reverse), for p21: 5'-GCACTGAATGCCAAGGGAA-3' (forward) and 5'-GCAATAACGGGAGGAGCA-3' (reverse), and for beta-actin: 5'-ATCATGTTTGAGACCTTCAACA-3' (forward) and 5'-CATCTCTTGCTCGAAGTCCA-3' (reverse). NDRG2, p21 and beta-actin mRNAs were detected with SYBR Green PCR Master Mix and an ABI PRISM 7500 Sequence Detection System (Applied Biosystems, UK) using the comparative threshold cycle (CT) method for relative quantification. The PCR reaction consisted of 12.5 microl of SYBR Green PCR Master Mix, 300 nM of the forward and reverse primers and 1.5 microl template cDNA in a total volume of 25 microl. The thermal cycling conditions were as following: 95degreesC for 5 min, followed by 45 cycles of 95degreesC for 30 s, 58degreesC for 30 s and 72degreesC for 45 s. To verify that the primer pair produced a single product, a dissociation protocol was used following thermocycling to determine the dissociation of the PCR products from 65degreesC to 95degreesC.
###end p 13
###begin title 14
Western blot analysis
###end title 14
###begin p 15
###xml 716 727 <span type="species:ncbi:3704">horseradish</span>
Cells were harvested from 60-mm culture dishes and were lyzed in 200 mul of RIPA buffer [0.05 M Tris-HCl pH 7.4, 0.15 M NaCl, 0.25% deoxycholic acid, 1% Nonidet P-40 (NP-40), 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 1 mug/ml aprotinin and 1 mug/ml leupeptin]. Protein concentrations were measured using the BCA protein assay (Pierce, Rockford, IL, USA). Proteins were separated by SDS-PAGE and transferred to Hybond-ECL nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ, USA). Western blot analyses were carried out using the following primary antibodies: anti-p53, anti-Ndrg2, anti-p21 and anti-beta-actin antibodies (Santa Cruz Biotechnology, CA, USA), followed by incubation in species-matched horseradish peroxidase (HRP)-conjugated secondary antibodies. The blots were developed with chemiluminescence substrate solution (Pierce) and exposed to X-ray film.
###end p 15
###begin title 16
Construction of reporter plasmids
###end title 16
###begin p 17
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 167 170 167 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mlu</italic>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 480 481 480 481 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sc>
###xml 483 484 483 484 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sc>
###xml 494 495 494 495 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sc>
###xml 497 498 497 498 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sc>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
A 24-bp fragment (5'-CGCGTGTGCAAGGTCCGGGGCGCTTGGCAA-3') that contains the potential p53-binding sites (p53BSs) from NDRG2 intron 1 was synthesized and cloned into the Mlu I and Bgl II sites of the pGL3-promoter luciferase vector (pGL3-P-luc; Promega). The pGL3-P-luc contains an SV-40 promoter upstream of the luciferase reporter gene. The resulting construct was named pGL3-p-NDRG2. A relative fragment containing four nucleotides point mutations, shown in lowercase (5'-CGCGTGTGtAAtGTCCGGGGCGaTTaGCAA-3'), which are predicated to be critical for p53 binding was also generated and cloned into the reporter vector and named pGL3-p-NDRG2-m.
###end p 17
###begin p 18
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 244 249 244 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mlu</italic>
###xml 532 535 532 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
The 1379 bp (-56/+1323 bp) and the 688 bp (-56/+632 bp) DNA fragments, which either contain or delete the intronic p53BSs of the NDRG2 intron 1, respectively, were amplified from the A549 genomic DNA by PCR. The following primers were used for NDRG2-p53BSs: 5'-GCACGCGTGTTGGCCATCCTCTCCCCACC-3' (forward) and 5'-GCAGATCTAGGGGGACTAAACGCGGGGGAATA-3' (reverse), and for NDRG2-p53BSs-del, 5'-GCACGCGCTGTTGGCCATCCTCTCCCCACC-3' (forward) and 5'-GCAGATCTCCCGCAGACCCGCCCCAGACC-3' (reverse). These PCR products were cloned into the Mlu I and Bgl II sites of the pGL3-basic luciferase vector (pGL3-B-luc; Promega). The corresponding constructs were named pGL3-B-NDRG2-p53BSs and pGL3-B-NDRG2-p53BSs-del, respectively.
###end p 18
###begin title 19
Transfection and reporter gene assay
###end title 19
###begin p 20
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 371 378 369 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 412 415 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 685 688 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Cells were seeded in a 24-well plate at a density of 1 x 105 cells/well and transfected the next day using Lipofectamine 2000 (Invitrogen Life Technologies), according to the manufacturer's protocol. Briefly, for HEK 293 cells, 0.1 mug of the reporter vector was cotransfected with 1 mug of the pcDNA3.1(+) control vector or a vector that expresses wt or mutant p53. The Renilla luciferase vector (0.01 mug, pRL-CMV, Promega) was also cotransfected as an internal control. Luciferase activity was measured 36 h after transfection using the dual-luciferase reporter assay system. For A549, MDA-MB-231 and Saos2 cells, 1 mug of the reporter genes were cotransfected with 0.01 mug of pRL-CMV. Then 12 h after transfection, the cells were treated with 0.4 mug Adr for 24 h and the luciferase activity was measured.
###end p 20
###begin title 21
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Treatment of cells with siRNA for p53 and NDRG2
###end title 21
###begin p 22
###xml 19 21 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG</italic>
###xml 299 304 299 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 103 108 <span type="species:ncbi:9606">human</span>
The siRNA pSilencerTM3.1-H1 neo vector system was utilized and the siRNA motifs were selected from the human p53 or NDRG2 cDNA sequence according to the AA-N19 rule (). The target sequence for p53 (NM_000546) is localized at positions 734-bp downstream from the start codon. The target sequence for NDRG2 (AF159092) is localized at positions 604-bp downstream from the start codon.
###end p 22
###begin title 23
Chromatin immunoprecipitation assay
###end title 23
###begin p 24
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 331 332 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1057 1062 1024 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1099 1104 1066 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1239 1244 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
The chromatin immunoprecipitation (ChIP) analysis was performed using the ChIP Assay kit (Upstate Biotechnology, Charlottesville, VA, USA). After infection with Ad-p53 or Ad-LacZ for 48 h, 2 x 106 Saos2 cells were cross-linked with 1% formaldehyde for 10 min at 37degreesC. After treatment with 0.4 mug Adr or DMSO for 24 h, 6 x 106 A549 cells were cross-linked with 1% formaldehyde for 10 min at 37degreesC. The cells were then washed, lyzed and sonicated to generate 200-500 bp DNA fragments. The samples were precleared with 60 microl of salmon sperm DNA-protein A-agarose and subsequently incubated at 4degreesC overnight with 5 microg anti-p53 antibody (Santa Cruz Biotechnology, CA, USA), with mIgG and no antibody serving as control. Immunocomplexes were recovered, washed thoroughly and eluted with the ChIP elution buffer. Following the reversal of cross-links at 65degreesC for 4 h, samples were extracted with phenol/chloroform, precipitated with ethanol and then used as templates for PCR amplification, using primers flanking the p53BSs in the NDRG2 intron 1 or the control region. For NDRG2 p53BSs, forward primer 5'-CAAAGGCTGAGGCTCCAAGAG-3' (+889/+910 bp), reverse primer 5'-TCGGGAAGGGATGGGTAGG-3' (+1063/+1082 bp). For the NDRG2 negative control, forward primer 5'-GTTAGCGGCGAAGCCACAGG-3' (-235/-215 bp), reverse primer 5'-TGGGGTCAATGCCTCAAGGG-3' (-82/-62 bp). The PCR products generated from the ChIP assay were sequenced to verify the identity of the amplified DNA.
###end p 24
###begin title 25
Electrophoretic mobility shift assay
###end title 25
###begin p 26
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 885 890 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1015 1020 1006 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1116 1121 1107 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1341 1346 1331 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1360 1365 1350 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Electrophoretic mobility shift assay (EMSA) was performed according to the EMSA kit procedure (Pierce). Nuclear extracts were prepared from A549 cells treated with or without Adr or from Saos2 cells infected with Ad-p53 or Ad-LacZ. Then endogenous or exogenous p53 protein was prepared using the NE-PER nuclear and cytoplasmic extraction reagents. Briefly, cells (1 x 107) were resuspended in 200 mul cytoplasmic extraction reagent (CER) I containing protease inhibitors, incubated on ice for 10 min and then 11 mul of CER II was added and incubated for 1 min on ice. After centrifugation at 12 000 r.p.m. for 10 min, the cell pellets were resuspended in 50 mul nuclear extraction reagent (NER) containing protease inhibitors and rotated at 4degreesC for 1 h. Supernatants with nuclear proteins were recovered by centrifugation at 12 000 r.p.m. for 15 min. The candidate p53BSs in the NDRG2 intron 1 and the corresponding complementary sequence (5'-TGTGTGCAAGGTCCGGGGCGCTTGGCACCG-3') were prepared as probes, named NDRG2-wt-p53BSs. A mutant version (5'-TGTGTGTAATGTCCGGGGCGATTAGCACCG-3') was also prepared and named NDRG2-mt-p53BSs. A 5'-biotin modification was included in all probes except for the competitor oligonucleotides, which did not contain any modifications. Nuclear proteins (3 mug) were incubated with 10 fmol of biotin-labeled NDRG2-wt-p53BSs or NDRG2-mt-p53BSs, and the DNA-protein complexes were separated on a 6% nondenaturing polyacrylamide gel in 0.5 x TBE with 2.5% glycerol and transferred to positively charged nylon membranes. The membranes were blocked with blocking buffer and incubated with HRP-conjugated streptavidin. The blots were developed with chemiluminescence substrate solution (Pierce) and exposed to X-ray film. For competition assays, 100- or 200-fold excess of unlabeled probes were added to the reaction mixture for 1 h at room temperature before the addition of the labeled probe.
###end p 26
###begin title 27
Adenovirus infection
###end title 27
###begin p 28
Adenoviruses carrying wt-p53 (Ad-p53) or the negative control Lac Z (Ad-lac Z) were purchased from Benyuan Zhengyang Company (Beijing, China). The multiplicity of infection (MOI) was determined for the Saos2 and H1299 cell lines.
###end p 28
###begin title 29
Gene transfection
###end title 29
###begin p 30
All transfections were performed with lipofectamine 2000 (Invitrogen Life Technologies), according to the manufacturer's instructions. For stable transfection, single colonies were obtained after selection with G418 (Saos2, 500 microg/ml; A549, 600 microg/ml) for 4 weeks. All clones were analyzed using western blot analysis.
###end p 30
###begin title 31
MTT assay
###end title 31
###begin p 32
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
The cells were seeded into 96-well plates at a starting density of 1 x 103 cells/well in triplicate. At each time point, the cells were washed and incubated with tetrazolium salt (MTT, 100 microg/ml, Sigma) at 37degreesC for 4 h. The supernatant was removed, and 150 microl DMSO was added to each well. The absorbance (OD) of the reaction solution at 570 nm was recorded. Each experiment was performed in triplicate, and the values were reported as the mean +/- SD.
###end p 32
###begin title 33
Colony formation assay
###end title 33
###begin p 34
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Saos2 cells, which were stably transfected with either the empty vector [pcDNA3.1(+)] or the vector carrying Flag-tagged NDRG2 [pcDNA3.1(+)-F-2 and pCDNA 3.1(+)-F-4], were seeded into 6-cm dishes at a density of 200 cells/dish. The cells were grown for 4 weeks in selective culturing medium (G418, 500 microg/ml). Then, the colonies were fixed and stained with Coomassie blue.
###end p 34
###begin title 35
Detection of apoptosis
###end title 35
###begin p 36
###xml 550 557 550 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 594 595 594 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
Apoptosis was detected using flow cytometry analysis and the terminal uridine deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. For flow cytometry, cells were harvested following mild trypsinization and were washed with phosphate-buffered saline (PBS). Cell death was measured using two-color analysis of fluorescein isothiocyanate-labeled annexin V (Roche Applied Science) binding and propidium iodide (PI) uptake using a Becton Dickinson fluorescence-activated cell sorter (FACS) apparatus. For the TUNEL assay, the Apoptag Direct in situ Apoptosis Detection Kit-Fluoresence (Roche Applied Science, Basel, Switzerland) were used to detect DNA fragmentation in apoptotic cells by direct end-labeling of cellular genomic DNA with a fluorescein-conjugated nucleotide using the terminal deoxynucleotidyltransferase enzyme. Cells were washed, fixed in 4% formaldehyde in PBS for 30 min at room temperature and stored dry on aminoalkylsilane-coated slides at -20degreesC before processing. 4',6-Diamidino-2-phenylindole (DAPI) was used for counterstaining. The cells fixed on slides were observed using a fluorescence microscope.
###end p 36
###begin title 37
Statistical analysis
###end title 37
###begin p 38
###xml 150 151 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 230 233 228 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P &lt;</italic>
Data are expressed as the mean +/- SD. Statistical analyses were performed with the SPSS software (version 10.0; SPSS, Chicago, IL, USA) by using the t-test for independent groups. Statistical significance was based on a value of P < 0.05.
###end p 38
###begin title 39
RESULTS
###end title 39
###begin title 40
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Induction of NDRG2 by DNA-damaging agents or stress is p53 dependent
###end title 40
###begin p 41
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 460 468 460 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 656 664 656 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 763 768 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 796 804 796 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 848 853 848 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 994 1002 994 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1240 1248 1240 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1330 1338 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 1402 1407 1402 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1459 1468 1459 1468 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1.</label>
###xml 1481 1486 1481 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1558 1559 1558 1559 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1579 1584 1579 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1738 1739 1737 1738 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1896 1897 1894 1895 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1917 1922 1915 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 2090 2091 2087 2088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2120 2121 2117 2118 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 2278 2279 2274 2275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 2308 2309 2304 2305 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 2478 2479 2473 2474 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 2499 2504 2494 2499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 2635 2636 2629 2630 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1468 3005 1468 2998 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="42">Induction of <italic>NDRG2</italic> by DNA-damaging reagents or stress depends on the presence of wt p53. (<bold>A</bold>) The levels of the <italic>NDRG2</italic> and p21 transcripts were assessed by real-time PCR assays in A549 cells and U87 cells that were treated with Adr (0.2 &#956;g/ml) for 0, 3, 6, 12 and 24 h. (<bold>B</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with 0.2 &#956;g/ml Adr for 0, 3, 6, 12 and 24 h. (<bold>C</bold>) The levels of the <italic>NDRG2</italic> and p21 transcripts were assessed by real-time PCR assays in A549 cells that were treated with methyl methanesulfonate (MMS, 120 &#956;g/ml) or irradiated with UV (7.5 J/m<sup>2</sup>) for 0, 3, 6, 12 and 24 h. (<bold>D</bold>) The levels of the Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with MMS (120 &#956;g/ml) or irradiated with UV (7.5 J/m<sup>2</sup>) for 0, 3, 6, 12 and 24 h. (<bold>E</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in MDA-MB-231 and SKBR-3 cells that were treated with or without 0.2 &#956;g/ml Adr for 24 h. (<bold>F</bold>) The levels of the <italic>NDRG2</italic> transcripts were measured by real-time PCR assays in H1299 cells that were treated with 0.2 &#956;g/ml Adr for 0, 3, 6, 12 and 24 h. (<bold>G</bold>) A549 cells were transiently transfected with pSilencer3.1-p53 or pSilencer3.1-X and 24 h later, cells were treated with or without 0.2 &#956;g/ml Adr for 24 h. The levels of the p53 and Ndrg2 proteins were assessed by western blot. In (B), (D), (E) and (G), actin was used as a loading control. The experimental details are described in the Materials and methods section.</p>
###xml 1468 3005 1468 2998 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="42">Induction of <italic>NDRG2</italic> by DNA-damaging reagents or stress depends on the presence of wt p53. (<bold>A</bold>) The levels of the <italic>NDRG2</italic> and p21 transcripts were assessed by real-time PCR assays in A549 cells and U87 cells that were treated with Adr (0.2 &#956;g/ml) for 0, 3, 6, 12 and 24 h. (<bold>B</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with 0.2 &#956;g/ml Adr for 0, 3, 6, 12 and 24 h. (<bold>C</bold>) The levels of the <italic>NDRG2</italic> and p21 transcripts were assessed by real-time PCR assays in A549 cells that were treated with methyl methanesulfonate (MMS, 120 &#956;g/ml) or irradiated with UV (7.5 J/m<sup>2</sup>) for 0, 3, 6, 12 and 24 h. (<bold>D</bold>) The levels of the Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with MMS (120 &#956;g/ml) or irradiated with UV (7.5 J/m<sup>2</sup>) for 0, 3, 6, 12 and 24 h. (<bold>E</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in MDA-MB-231 and SKBR-3 cells that were treated with or without 0.2 &#956;g/ml Adr for 24 h. (<bold>F</bold>) The levels of the <italic>NDRG2</italic> transcripts were measured by real-time PCR assays in H1299 cells that were treated with 0.2 &#956;g/ml Adr for 0, 3, 6, 12 and 24 h. (<bold>G</bold>) A549 cells were transiently transfected with pSilencer3.1-p53 or pSilencer3.1-X and 24 h later, cells were treated with or without 0.2 &#956;g/ml Adr for 24 h. The levels of the p53 and Ndrg2 proteins were assessed by western blot. In (B), (D), (E) and (G), actin was used as a loading control. The experimental details are described in the Materials and methods section.</p></caption>
###xml 3005 3005 2998 2998 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f1a"/>
###xml 3005 3005 2998 2998 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f1b"/>
###xml 1459 3005 1459 2998 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1.</label><caption><p textid="42">Induction of <italic>NDRG2</italic> by DNA-damaging reagents or stress depends on the presence of wt p53. (<bold>A</bold>) The levels of the <italic>NDRG2</italic> and p21 transcripts were assessed by real-time PCR assays in A549 cells and U87 cells that were treated with Adr (0.2 &#956;g/ml) for 0, 3, 6, 12 and 24 h. (<bold>B</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with 0.2 &#956;g/ml Adr for 0, 3, 6, 12 and 24 h. (<bold>C</bold>) The levels of the <italic>NDRG2</italic> and p21 transcripts were assessed by real-time PCR assays in A549 cells that were treated with methyl methanesulfonate (MMS, 120 &#956;g/ml) or irradiated with UV (7.5 J/m<sup>2</sup>) for 0, 3, 6, 12 and 24 h. (<bold>D</bold>) The levels of the Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with MMS (120 &#956;g/ml) or irradiated with UV (7.5 J/m<sup>2</sup>) for 0, 3, 6, 12 and 24 h. (<bold>E</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in MDA-MB-231 and SKBR-3 cells that were treated with or without 0.2 &#956;g/ml Adr for 24 h. (<bold>F</bold>) The levels of the <italic>NDRG2</italic> transcripts were measured by real-time PCR assays in H1299 cells that were treated with 0.2 &#956;g/ml Adr for 0, 3, 6, 12 and 24 h. (<bold>G</bold>) A549 cells were transiently transfected with pSilencer3.1-p53 or pSilencer3.1-X and 24 h later, cells were treated with or without 0.2 &#956;g/ml Adr for 24 h. The levels of the p53 and Ndrg2 proteins were assessed by western blot. In (B), (D), (E) and (G), actin was used as a loading control. The experimental details are described in the Materials and methods section.</p></caption><graphic xlink:href="gkn504f1a"/><graphic xlink:href="gkn504f1b"/></fig>
Adr, as a topoisomerase II inhibitor, is able to induce double-strand DNA breaks, and consequently stabilize and activate p53, which results in the induction of p53 target genes (13,49). To explore the relationship between NDRG2 and p53, we first examined the changes of NDRG2 mRNA and protein levels in response to p53 activation by Adr. Adr treatment resulted in increased expression of NDRG2 and p21 in both A549 and U87 cells as measured by real-time PCR (Figure 1A). The increase in NDRG2 mRNA began after 3 h and was significant 6 h following Adr treatment. Additionally, Ndrg2 protein expression increased in A549 cells as detected by western blot (Figure 1B). Two other classical p53 inducible treatment (MMS and UV) can also upregulate the expression of NDRG2 in mRNA and protein level (Figure 1C and D). In contrast, the effect of Adr on NDRG2 expression was not observed in either the mutant p53-bearing cell lines, including MDA-MB-231 and SK-BR-3, or the H1299 p53 null cell line (Figure 1E and F). To further confirm that upregulation of Ndrg2 is p53-dependent, we transfected A549 cells with pSilencer3.1-p53 to knockdown endogenous p53, treated them with Adr and then observed the change of Ndrg2 protein level. As shown in Figure 1G, reduction of endogenous p53 markedly attenuated Adr-induced increase of Ndrg2 (Figure 1G). These data strongly suggest that the elevated expression of NDRG2 by DNA-damaging agents or stress is p53 dependent. Figure 1.Induction of NDRG2 by DNA-damaging reagents or stress depends on the presence of wt p53. (A) The levels of the NDRG2 and p21 transcripts were assessed by real-time PCR assays in A549 cells and U87 cells that were treated with Adr (0.2 mug/ml) for 0, 3, 6, 12 and 24 h. (B) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with 0.2 mug/ml Adr for 0, 3, 6, 12 and 24 h. (C) The levels of the NDRG2 and p21 transcripts were assessed by real-time PCR assays in A549 cells that were treated with methyl methanesulfonate (MMS, 120 mug/ml) or irradiated with UV (7.5 J/m2) for 0, 3, 6, 12 and 24 h. (D) The levels of the Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with MMS (120 mug/ml) or irradiated with UV (7.5 J/m2) for 0, 3, 6, 12 and 24 h. (E) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in MDA-MB-231 and SKBR-3 cells that were treated with or without 0.2 mug/ml Adr for 24 h. (F) The levels of the NDRG2 transcripts were measured by real-time PCR assays in H1299 cells that were treated with 0.2 mug/ml Adr for 0, 3, 6, 12 and 24 h. (G) A549 cells were transiently transfected with pSilencer3.1-p53 or pSilencer3.1-X and 24 h later, cells were treated with or without 0.2 mug/ml Adr for 24 h. The levels of the p53 and Ndrg2 proteins were assessed by western blot. In (B), (D), (E) and (G), actin was used as a loading control. The experimental details are described in the Materials and methods section.
###end p 41
###begin p 42
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 90 91 90 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 111 116 111 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 270 271 269 270 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 428 429 426 427 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 449 454 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 622 623 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 652 653 649 650 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 810 811 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 840 841 836 837 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1010 1011 1005 1006 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1031 1036 1026 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1167 1168 1161 1162 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
Induction of NDRG2 by DNA-damaging reagents or stress depends on the presence of wt p53. (A) The levels of the NDRG2 and p21 transcripts were assessed by real-time PCR assays in A549 cells and U87 cells that were treated with Adr (0.2 mug/ml) for 0, 3, 6, 12 and 24 h. (B) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with 0.2 mug/ml Adr for 0, 3, 6, 12 and 24 h. (C) The levels of the NDRG2 and p21 transcripts were assessed by real-time PCR assays in A549 cells that were treated with methyl methanesulfonate (MMS, 120 mug/ml) or irradiated with UV (7.5 J/m2) for 0, 3, 6, 12 and 24 h. (D) The levels of the Ndrg2 and p21 proteins were assessed by western blot in A549 cells that were treated with MMS (120 mug/ml) or irradiated with UV (7.5 J/m2) for 0, 3, 6, 12 and 24 h. (E) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in MDA-MB-231 and SKBR-3 cells that were treated with or without 0.2 mug/ml Adr for 24 h. (F) The levels of the NDRG2 transcripts were measured by real-time PCR assays in H1299 cells that were treated with 0.2 mug/ml Adr for 0, 3, 6, 12 and 24 h. (G) A549 cells were transiently transfected with pSilencer3.1-p53 or pSilencer3.1-X and 24 h later, cells were treated with or without 0.2 mug/ml Adr for 24 h. The levels of the p53 and Ndrg2 proteins were assessed by western blot. In (B), (D), (E) and (G), actin was used as a loading control. The experimental details are described in the Materials and methods section.
###end p 42
###begin title 43
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Ectopic expression of p53 results in upregulation of NDRG2
###end title 43
###begin p 44
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 444 449 444 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 496 504 496 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 697 705 697 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 725 730 725 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 757 766 757 766 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2.</label>
###xml 819 824 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 827 828 827 828 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 988 989 988 989 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1145 1146 1145 1146 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1166 1171 1166 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1331 1332 1331 1332 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 766 1622 766 1622 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="45">Exogenous, overexpressed p53 induces upregulation of <italic>NDRG2</italic>. (<bold>A</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with Ad-LacZ or different MOI Ad-p53 for 48 h. (<bold>B</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with 40 MOI Ad-p53 for 0, 24, 48 and 72 h. (<bold>C</bold>) The levels of the <italic>NDRG2</italic> transcripts were measured by real-time PCR assays in H1299 cells that were infected with Ad-LacZ for 24 h or with 40 MOI Ad-p53 for 0, 3, 6, 12, 24 and 48 h. (<bold>D</bold>) H1299 cells were transfected with pcDNA3.1(+), pcDNA3.1(+)-wt-p53, pcDNA3.1(+)-175H or pcDNA3.1(+)-248W, respectively. Twenty-four hours after transfection, the protein levels of p53, Ndrg2 and p21 were determined by western blot. In (A), (B) and (D), actin was used as a loading control.</p>
###xml 766 1622 766 1622 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="45">Exogenous, overexpressed p53 induces upregulation of <italic>NDRG2</italic>. (<bold>A</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with Ad-LacZ or different MOI Ad-p53 for 48 h. (<bold>B</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with 40 MOI Ad-p53 for 0, 24, 48 and 72 h. (<bold>C</bold>) The levels of the <italic>NDRG2</italic> transcripts were measured by real-time PCR assays in H1299 cells that were infected with Ad-LacZ for 24 h or with 40 MOI Ad-p53 for 0, 3, 6, 12, 24 and 48 h. (<bold>D</bold>) H1299 cells were transfected with pcDNA3.1(+), pcDNA3.1(+)-wt-p53, pcDNA3.1(+)-175H or pcDNA3.1(+)-248W, respectively. Twenty-four hours after transfection, the protein levels of p53, Ndrg2 and p21 were determined by western blot. In (A), (B) and (D), actin was used as a loading control.</p></caption>
###xml 1622 1622 1622 1622 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f2"/>
###xml 757 1622 757 1622 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2.</label><caption><p textid="45">Exogenous, overexpressed p53 induces upregulation of <italic>NDRG2</italic>. (<bold>A</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with Ad-LacZ or different MOI Ad-p53 for 48 h. (<bold>B</bold>) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with 40 MOI Ad-p53 for 0, 24, 48 and 72 h. (<bold>C</bold>) The levels of the <italic>NDRG2</italic> transcripts were measured by real-time PCR assays in H1299 cells that were infected with Ad-LacZ for 24 h or with 40 MOI Ad-p53 for 0, 3, 6, 12, 24 and 48 h. (<bold>D</bold>) H1299 cells were transfected with pcDNA3.1(+), pcDNA3.1(+)-wt-p53, pcDNA3.1(+)-175H or pcDNA3.1(+)-248W, respectively. Twenty-four hours after transfection, the protein levels of p53, Ndrg2 and p21 were determined by western blot. In (A), (B) and (D), actin was used as a loading control.</p></caption><graphic xlink:href="gkn504f2"/></fig>
To directly investigate whether p53 can upregulate NDRG2 expression, we examined the effect of exogenously introduced p53 via either adenoviral infection or gene transfection on the expression of NDRG2 in p53 null H1299 cells. We found that the Ndrg2 protein level was upregulated due to the increase in exogenous p53 following adenovirus infection, similar to p21, which is a known p53 target gene (Figure 2A and B). We also detected that the NDRG2 mRNA level increased with p53 overexpression (Figure 2C), suggesting that the effect occurred at the transcriptional level. Meanwhile, transfection of only the wt p53, but not the mutant forms (175H and 248W), upregulated the expression of NDRG2 (Figure 2D), indicating that NDRG2 may be a p53 target gene. Figure 2.Exogenous, overexpressed p53 induces upregulation of NDRG2. (A) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with Ad-LacZ or different MOI Ad-p53 for 48 h. (B) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with 40 MOI Ad-p53 for 0, 24, 48 and 72 h. (C) The levels of the NDRG2 transcripts were measured by real-time PCR assays in H1299 cells that were infected with Ad-LacZ for 24 h or with 40 MOI Ad-p53 for 0, 3, 6, 12, 24 and 48 h. (D) H1299 cells were transfected with pcDNA3.1(+), pcDNA3.1(+)-wt-p53, pcDNA3.1(+)-175H or pcDNA3.1(+)-248W, respectively. Twenty-four hours after transfection, the protein levels of p53, Ndrg2 and p21 were determined by western blot. In (A), (B) and (D), actin was used as a loading control.
###end p 44
###begin p 45
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 61 62 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 222 223 222 223 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 379 380 379 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 565 566 565 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
Exogenous, overexpressed p53 induces upregulation of NDRG2. (A) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with Ad-LacZ or different MOI Ad-p53 for 48 h. (B) The levels of the p53, Ndrg2 and p21 proteins were assessed by western blot in H1299 cells that were infected with 40 MOI Ad-p53 for 0, 24, 48 and 72 h. (C) The levels of the NDRG2 transcripts were measured by real-time PCR assays in H1299 cells that were infected with Ad-LacZ for 24 h or with 40 MOI Ad-p53 for 0, 3, 6, 12, 24 and 48 h. (D) H1299 cells were transfected with pcDNA3.1(+), pcDNA3.1(+)-wt-p53, pcDNA3.1(+)-175H or pcDNA3.1(+)-248W, respectively. Twenty-four hours after transfection, the protein levels of p53, Ndrg2 and p21 were determined by western blot. In (A), (B) and (D), actin was used as a loading control.
###end p 45
###begin title 46
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
The putative p53-binding site in NDRG2 intron 1 is responsive to p53
###end title 46
###begin p 47
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 230 231 230 231 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sc>
###xml 236 237 236 237 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</sc>
###xml 244 245 244 245 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sc>
###xml 250 251 250 251 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</sc>
###xml 252 253 252 253 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sc>
###xml 259 267 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 384 393 384 393 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3.</label>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 518 523 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 535 536 535 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 733 734 733 734 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 774 779 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 922 927 921 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 938 943 937 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1133 1134 1132 1133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1174 1179 1173 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1296 1301 1295 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1312 1317 1311 1316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1444 1445 1443 1444 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1489 1494 1488 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1631 1636 1630 1635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1758 1759 1757 1758 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1798 1803 1797 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1821 1826 1820 1825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 2047 2054 2046 2053 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2150 2157 2149 2156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2316 2323 2315 2322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2437 2438 2436 2437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 393 2472 393 2471 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="48">The putative p53-binding site in intron 1 of <italic>NDRG2</italic> is responsive to p53 and is required for p53-dependent transactivation of <italic>NDRG2</italic> promoter. (<bold>A</bold>) Shown are the wt putative p53-binding site located within <italic>NDRG2</italic> intron 1, its corresponding mutant version and a schematic diagram of the various reporter vectors used in the luciferase assays. (<bold>B</bold>) Activation of the p53-binding site in <italic>NDRG2</italic> intron 1 by exogenous wt p53. HEK293 cells were individually cotransfected with an equal amount (0.1 &#956;g) of reporter vectors (pGL3-p, pGL3-p-<italic>NDRG2</italic> or pGL3-p-<italic>NDRG2</italic>-m) and either empty vector pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H]. Luciferase activity was determined 36 h following transfection. (<bold>C</bold>) Activation of the p53-binding site in <italic>NDRG2</italic> intron 1 by endogenous p53 in response to DNA damage in A549 cells. A549 cells were transfected with pGL3-p, pGL3-p-<italic>NDRG2</italic> or pGL3-p-<italic>NDRG2</italic>-m, and 12 h later, the cells were treated with the indicated amount of Adr for 24 h, and luciferase activity was determined. (<bold>D</bold>) Responsiveness of the p53-binding site in <italic>NDRG2</italic> intron 1 to endogenous p53 depends on the presence of wt p53. A549, MDA-MB-231 or Saos2 cells were individually transfected with pGL3-p-<italic>NDRG2</italic>, 12 h later, cells were treated with the indicated amount of Adr for 24 h, and then luciferase activity was determined. (<bold>E</bold>) The reporter vectors (pGL3-B, pGL3-B-<italic>NDRG2</italic>-P53BSs or pGL3-B-<italic>NDRG2</italic>-P53BSs-del) were cotransfected into HEK293 cells with either pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H], and 36 h later, luciferase activity was determined. In (B&#8211;D), <italic>Renilla</italic> luciferase vector pRL-CMV was also cotransfected as an internal control vector. Luciferase and <italic>Renilla</italic> activity was assayed using the Dual-Luciferase Reporter Assay System (Promega), and luciferase fold activation values were measured relative to the levels of <italic>Renilla</italic> activity. The histograms represent the average of three independent experiments with error bars showing the SD. *<italic>P</italic> &lt; 0.05 among each compared group.</p>
###xml 393 2472 393 2471 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="48">The putative p53-binding site in intron 1 of <italic>NDRG2</italic> is responsive to p53 and is required for p53-dependent transactivation of <italic>NDRG2</italic> promoter. (<bold>A</bold>) Shown are the wt putative p53-binding site located within <italic>NDRG2</italic> intron 1, its corresponding mutant version and a schematic diagram of the various reporter vectors used in the luciferase assays. (<bold>B</bold>) Activation of the p53-binding site in <italic>NDRG2</italic> intron 1 by exogenous wt p53. HEK293 cells were individually cotransfected with an equal amount (0.1 &#956;g) of reporter vectors (pGL3-p, pGL3-p-<italic>NDRG2</italic> or pGL3-p-<italic>NDRG2</italic>-m) and either empty vector pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H]. Luciferase activity was determined 36 h following transfection. (<bold>C</bold>) Activation of the p53-binding site in <italic>NDRG2</italic> intron 1 by endogenous p53 in response to DNA damage in A549 cells. A549 cells were transfected with pGL3-p, pGL3-p-<italic>NDRG2</italic> or pGL3-p-<italic>NDRG2</italic>-m, and 12 h later, the cells were treated with the indicated amount of Adr for 24 h, and luciferase activity was determined. (<bold>D</bold>) Responsiveness of the p53-binding site in <italic>NDRG2</italic> intron 1 to endogenous p53 depends on the presence of wt p53. A549, MDA-MB-231 or Saos2 cells were individually transfected with pGL3-p-<italic>NDRG2</italic>, 12 h later, cells were treated with the indicated amount of Adr for 24 h, and then luciferase activity was determined. (<bold>E</bold>) The reporter vectors (pGL3-B, pGL3-B-<italic>NDRG2</italic>-P53BSs or pGL3-B-<italic>NDRG2</italic>-P53BSs-del) were cotransfected into HEK293 cells with either pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H], and 36 h later, luciferase activity was determined. In (B&#8211;D), <italic>Renilla</italic> luciferase vector pRL-CMV was also cotransfected as an internal control vector. Luciferase and <italic>Renilla</italic> activity was assayed using the Dual-Luciferase Reporter Assay System (Promega), and luciferase fold activation values were measured relative to the levels of <italic>Renilla</italic> activity. The histograms represent the average of three independent experiments with error bars showing the SD. *<italic>P</italic> &lt; 0.05 among each compared group.</p></caption>
###xml 2472 2472 2471 2471 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f3"/>
###xml 384 2472 384 2471 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3.</label><caption><p textid="48">The putative p53-binding site in intron 1 of <italic>NDRG2</italic> is responsive to p53 and is required for p53-dependent transactivation of <italic>NDRG2</italic> promoter. (<bold>A</bold>) Shown are the wt putative p53-binding site located within <italic>NDRG2</italic> intron 1, its corresponding mutant version and a schematic diagram of the various reporter vectors used in the luciferase assays. (<bold>B</bold>) Activation of the p53-binding site in <italic>NDRG2</italic> intron 1 by exogenous wt p53. HEK293 cells were individually cotransfected with an equal amount (0.1 &#956;g) of reporter vectors (pGL3-p, pGL3-p-<italic>NDRG2</italic> or pGL3-p-<italic>NDRG2</italic>-m) and either empty vector pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H]. Luciferase activity was determined 36 h following transfection. (<bold>C</bold>) Activation of the p53-binding site in <italic>NDRG2</italic> intron 1 by endogenous p53 in response to DNA damage in A549 cells. A549 cells were transfected with pGL3-p, pGL3-p-<italic>NDRG2</italic> or pGL3-p-<italic>NDRG2</italic>-m, and 12 h later, the cells were treated with the indicated amount of Adr for 24 h, and luciferase activity was determined. (<bold>D</bold>) Responsiveness of the p53-binding site in <italic>NDRG2</italic> intron 1 to endogenous p53 depends on the presence of wt p53. A549, MDA-MB-231 or Saos2 cells were individually transfected with pGL3-p-<italic>NDRG2</italic>, 12 h later, cells were treated with the indicated amount of Adr for 24 h, and then luciferase activity was determined. (<bold>E</bold>) The reporter vectors (pGL3-B, pGL3-B-<italic>NDRG2</italic>-P53BSs or pGL3-B-<italic>NDRG2</italic>-P53BSs-del) were cotransfected into HEK293 cells with either pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H], and 36 h later, luciferase activity was determined. In (B&#8211;D), <italic>Renilla</italic> luciferase vector pRL-CMV was also cotransfected as an internal control vector. Luciferase and <italic>Renilla</italic> activity was assayed using the Dual-Luciferase Reporter Assay System (Promega), and luciferase fold activation values were measured relative to the levels of <italic>Renilla</italic> activity. The histograms represent the average of three independent experiments with error bars showing the SD. *<italic>P</italic> &lt; 0.05 among each compared group.</p></caption><graphic xlink:href="gkn504f3"/></fig>
###xml 2077 2080 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
It is well known that the upstream regulatory regions and intronic regions of p53-regulated genes may contain p53BSs (50). By analyzing the genomic sequence of NDRG2, we identified a putative sequence for p53BSs in intron 1 (5'- GtGCAAGgTCCGGGGcGCTTGgCa-3') (Figure 3A). The sequence contains mismatches (shown in lower case) in the nonconserved positions within the consensus p53BS. Figure 3.The putative p53-binding site in intron 1 of NDRG2 is responsive to p53 and is required for p53-dependent transactivation of NDRG2 promoter. (A) Shown are the wt putative p53-binding site located within NDRG2 intron 1, its corresponding mutant version and a schematic diagram of the various reporter vectors used in the luciferase assays. (B) Activation of the p53-binding site in NDRG2 intron 1 by exogenous wt p53. HEK293 cells were individually cotransfected with an equal amount (0.1 mug) of reporter vectors (pGL3-p, pGL3-p-NDRG2 or pGL3-p-NDRG2-m) and either empty vector pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H]. Luciferase activity was determined 36 h following transfection. (C) Activation of the p53-binding site in NDRG2 intron 1 by endogenous p53 in response to DNA damage in A549 cells. A549 cells were transfected with pGL3-p, pGL3-p-NDRG2 or pGL3-p-NDRG2-m, and 12 h later, the cells were treated with the indicated amount of Adr for 24 h, and luciferase activity was determined. (D) Responsiveness of the p53-binding site in NDRG2 intron 1 to endogenous p53 depends on the presence of wt p53. A549, MDA-MB-231 or Saos2 cells were individually transfected with pGL3-p-NDRG2, 12 h later, cells were treated with the indicated amount of Adr for 24 h, and then luciferase activity was determined. (E) The reporter vectors (pGL3-B, pGL3-B-NDRG2-P53BSs or pGL3-B-NDRG2-P53BSs-del) were cotransfected into HEK293 cells with either pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H], and 36 h later, luciferase activity was determined. In (B-D), Renilla luciferase vector pRL-CMV was also cotransfected as an internal control vector. Luciferase and Renilla activity was assayed using the Dual-Luciferase Reporter Assay System (Promega), and luciferase fold activation values were measured relative to the levels of Renilla activity. The histograms represent the average of three independent experiments with error bars showing the SD. *P < 0.05 among each compared group.
###end p 47
###begin p 48
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 142 143 142 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 340 341 340 341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 529 534 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 545 550 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 740 741 739 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 781 786 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 903 908 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 919 924 918 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1051 1052 1050 1051 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1096 1101 1095 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1238 1243 1237 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1365 1366 1364 1365 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1405 1410 1404 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1428 1433 1427 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1654 1661 1653 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1757 1764 1756 1763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1923 1930 1922 1929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 2044 2045 2043 2044 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1684 1687 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The putative p53-binding site in intron 1 of NDRG2 is responsive to p53 and is required for p53-dependent transactivation of NDRG2 promoter. (A) Shown are the wt putative p53-binding site located within NDRG2 intron 1, its corresponding mutant version and a schematic diagram of the various reporter vectors used in the luciferase assays. (B) Activation of the p53-binding site in NDRG2 intron 1 by exogenous wt p53. HEK293 cells were individually cotransfected with an equal amount (0.1 mug) of reporter vectors (pGL3-p, pGL3-p-NDRG2 or pGL3-p-NDRG2-m) and either empty vector pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H]. Luciferase activity was determined 36 h following transfection. (C) Activation of the p53-binding site in NDRG2 intron 1 by endogenous p53 in response to DNA damage in A549 cells. A549 cells were transfected with pGL3-p, pGL3-p-NDRG2 or pGL3-p-NDRG2-m, and 12 h later, the cells were treated with the indicated amount of Adr for 24 h, and luciferase activity was determined. (D) Responsiveness of the p53-binding site in NDRG2 intron 1 to endogenous p53 depends on the presence of wt p53. A549, MDA-MB-231 or Saos2 cells were individually transfected with pGL3-p-NDRG2, 12 h later, cells were treated with the indicated amount of Adr for 24 h, and then luciferase activity was determined. (E) The reporter vectors (pGL3-B, pGL3-B-NDRG2-P53BSs or pGL3-B-NDRG2-P53BSs-del) were cotransfected into HEK293 cells with either pcDNA3.1(+) or a vector expressing wt p53 [pcDNA3.1(+)-wt-p53] or mutant p53 [pcDNA3.1(+)-175H], and 36 h later, luciferase activity was determined. In (B-D), Renilla luciferase vector pRL-CMV was also cotransfected as an internal control vector. Luciferase and Renilla activity was assayed using the Dual-Luciferase Reporter Assay System (Promega), and luciferase fold activation values were measured relative to the levels of Renilla activity. The histograms represent the average of three independent experiments with error bars showing the SD. *P < 0.05 among each compared group.
###end p 48
###begin p 49
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 400 408 400 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 952 960 952 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1004 1009 1004 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
To determine whether the putative binding site in NDRG2 was responsive to p53, a fragment containing this element was synthesized and cloned into a pGL3-promoter luciferase vector (pGL3-p-NDRG2). A mutant reporter vector, pGL3-p-NDRG2-m, was also generated by replacing the four nucleotides in the p53BSs (see Materials and methods section). The empty reporter vector, pGL3-p, served as the control (Figure 3A). Each reporter vector was cotransfected into HEK293 cells with either a pcDNA3.1(+) control vector or a vector expressing wt p53 or mutant p53 (R175H). We found that the wt p53 was capable of increasing the luciferase activity of pGL3-p-NDRG2 markedly, while the mutant p53 and empty vector did not. The luciferase activity was nearly 4-fold higher after transfection with pGL3-p-NDRG2 than after transfection with the control vector. When the p53BSs were mutated (pGL3-p-NDRG2-m), p53-mediated transactivation was significantly diminished (Figure 3B), implying that the p53BSs in intron 1 of NDRG2 are required for responsiveness to exogenous p53.
###end p 49
###begin p 50
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 316 324 314 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 413 418 411 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 490 498 488 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 559 564 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
We then examined the effect of activation of endogenous p53 via Adr treatment on the transactivation of the reporter vectors. We found that the luciferase activity of pGL3-p-NDRG2, rather than pGL3-p-NDRG2-m or pGL3-p, was markedly increased in wt p53-bearing A549 cells after treatment with 0.2 mug or 0.4 mug Adr (Figure 3C). In contrast, Adr treatment failed to increase the transcriptional activity of pGL3-p-NDRG2 in either mutant p53-bearing MDA-MB-231 cells or p53 null Saos2 cells (Figure 3D). Together, these results indicated that the p53BSs in the NDRG2 intron 1 is responsible for mediating p53-induced gene transactivation.
###end p 50
###begin p 51
###xml 49 54 49 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 351 356 351 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 405 413 405 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 896 904 896 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Next, we examined whether the intronic p53BSs in NDRG2 are required for driving p53-induced transactivation of its own promoter. We amplified the DNA fragments consisting of the NDRG2 promoter, exon 1 and intron 1 containing p53BSs and its corresponding mutant counterpart that lacked p53BSs, cloned them into pGL3-B-luc, and named the vectors pGL3-B-NDRG2-p53BS and pGL3-B-NDRG2-p53BS-del, respectively (Figure 3A). The pGL3-B vector served as the control. When each of these reporter vectors was cotransfected into HEK293 cells with either the pcDNA3.1(+) control vector or vectors expressing the wt p53 or mutant p53 (R175H), we observed that the luciferase activity of pGL3-B-NDRG2-p53BSs could be induced only by wt p53, and not by the mutant p53 or empty vector. Moreover, neither the wt nor the mutant p53 was capable of increasing the transcriptional activity of pGL3-B-NDRG2-p53BSs-del (Figure 3E), which strongly suggests that the intronic p53BSs are indispensable for p53-mediated transactivation of NDRG2.
###end p 51
###begin title 52
p53 binds directly to the p53-binding sites in NDRG2 intron 1
###end title 52
###begin p 53
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 299 307 299 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 673 682 673 682 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4.</label>
###xml 728 733 728 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 743 750 743 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 755 763 755 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 766 767 766 767 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 850 857 850 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1307 1312 1306 1311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1551 1552 1550 1551 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1557 1558 1556 1557 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1626 1631 1625 1630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1641 1649 1640 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1912 1917 1911 1916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1928 1933 1927 1932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1957 1962 1956 1961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 2038 2043 2037 2042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 2071 2076 2070 2075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 682 2249 682 2248 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="54">p53 binds to the putative p53-binding site of <italic>NDRG2</italic> intron 1 <italic>in vivo</italic> and <italic>in vitro</italic>. (<bold>A</bold>) Binding of exogenous or endogenous p53 to the p53-binding site in <italic>NDRG2</italic> intron 1 <italic>in vivo</italic> by the ChIP assay. Cell lysates from Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (left, upper and lower panel) or from A549 cells that were pretreated with 0.4 &#956;g/ml Adr or DMSO for 24 h (right, upper and lower panel) were prepared, cross-linked and immunoprecipitated in the presence or absence of p53-specific antibody. The immunoprecipitated samples were analyzed by PCR amplification using the primers flanking the p53BSs in <italic>NDRG2</italic> intron 1 or the control region, as indicated in the Materials and methods section. Genomic DNA and input chromatin (input), which represent portions of sonicated chromatin before immunoprecipitation, were both used as positive controls. (<bold>B</bold> and <bold>C</bold>) Binding of exogenous or endogenous p53 to the p53-binding site in <italic>NDRG2</italic> intron 1 <italic>in vitro</italic> was measured by EMSA. Nuclear extracts of Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (B) or of A549 cells that were pretreated with or without Adr for 24 h (C) were prepared and incubated with biotin-labeled wt or mutant probes for p53BSs in <italic>NDRG2</italic> intron 1 [<italic>NDRG2</italic>-wt-p53BSs (lanes 3&#8211;9); <italic>NDRG2</italic>-mt-p53BSs (lanes 1 and 2)], or together with competitive unlabeled probes [<italic>NDRG2</italic>-wt-p53BSs (lanes 5 and 6); <italic>NDRG2</italic>-mt-p53BSs (lane 8)]. DNA&#8211;protein complexes were separated on a 6% TBE gel, transferred to nylon membranes and shifted probes were detected with HRP-conjugated streptavidin.</p>
###xml 682 2249 682 2248 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="54">p53 binds to the putative p53-binding site of <italic>NDRG2</italic> intron 1 <italic>in vivo</italic> and <italic>in vitro</italic>. (<bold>A</bold>) Binding of exogenous or endogenous p53 to the p53-binding site in <italic>NDRG2</italic> intron 1 <italic>in vivo</italic> by the ChIP assay. Cell lysates from Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (left, upper and lower panel) or from A549 cells that were pretreated with 0.4 &#956;g/ml Adr or DMSO for 24 h (right, upper and lower panel) were prepared, cross-linked and immunoprecipitated in the presence or absence of p53-specific antibody. The immunoprecipitated samples were analyzed by PCR amplification using the primers flanking the p53BSs in <italic>NDRG2</italic> intron 1 or the control region, as indicated in the Materials and methods section. Genomic DNA and input chromatin (input), which represent portions of sonicated chromatin before immunoprecipitation, were both used as positive controls. (<bold>B</bold> and <bold>C</bold>) Binding of exogenous or endogenous p53 to the p53-binding site in <italic>NDRG2</italic> intron 1 <italic>in vitro</italic> was measured by EMSA. Nuclear extracts of Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (B) or of A549 cells that were pretreated with or without Adr for 24 h (C) were prepared and incubated with biotin-labeled wt or mutant probes for p53BSs in <italic>NDRG2</italic> intron 1 [<italic>NDRG2</italic>-wt-p53BSs (lanes 3&#8211;9); <italic>NDRG2</italic>-mt-p53BSs (lanes 1 and 2)], or together with competitive unlabeled probes [<italic>NDRG2</italic>-wt-p53BSs (lanes 5 and 6); <italic>NDRG2</italic>-mt-p53BSs (lane 8)]. DNA&#8211;protein complexes were separated on a 6% TBE gel, transferred to nylon membranes and shifted probes were detected with HRP-conjugated streptavidin.</p></caption>
###xml 2249 2249 2248 2248 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f4"/>
###xml 673 2249 673 2248 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4.</label><caption><p textid="54">p53 binds to the putative p53-binding site of <italic>NDRG2</italic> intron 1 <italic>in vivo</italic> and <italic>in vitro</italic>. (<bold>A</bold>) Binding of exogenous or endogenous p53 to the p53-binding site in <italic>NDRG2</italic> intron 1 <italic>in vivo</italic> by the ChIP assay. Cell lysates from Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (left, upper and lower panel) or from A549 cells that were pretreated with 0.4 &#956;g/ml Adr or DMSO for 24 h (right, upper and lower panel) were prepared, cross-linked and immunoprecipitated in the presence or absence of p53-specific antibody. The immunoprecipitated samples were analyzed by PCR amplification using the primers flanking the p53BSs in <italic>NDRG2</italic> intron 1 or the control region, as indicated in the Materials and methods section. Genomic DNA and input chromatin (input), which represent portions of sonicated chromatin before immunoprecipitation, were both used as positive controls. (<bold>B</bold> and <bold>C</bold>) Binding of exogenous or endogenous p53 to the p53-binding site in <italic>NDRG2</italic> intron 1 <italic>in vitro</italic> was measured by EMSA. Nuclear extracts of Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (B) or of A549 cells that were pretreated with or without Adr for 24 h (C) were prepared and incubated with biotin-labeled wt or mutant probes for p53BSs in <italic>NDRG2</italic> intron 1 [<italic>NDRG2</italic>-wt-p53BSs (lanes 3&#8211;9); <italic>NDRG2</italic>-mt-p53BSs (lanes 1 and 2)], or together with competitive unlabeled probes [<italic>NDRG2</italic>-wt-p53BSs (lanes 5 and 6); <italic>NDRG2</italic>-mt-p53BSs (lane 8)]. DNA&#8211;protein complexes were separated on a 6% TBE gel, transferred to nylon membranes and shifted probes were detected with HRP-conjugated streptavidin.</p></caption><graphic xlink:href="gkn504f4"/></fig>
To further verify that NDRG2 is a p53 target gene, ChIP and EMSA were performed to examine whether p53 directly binds to the p53BSs in intron 1 of NDRG2. First, we demonstrated that both exogenous and endogenous p53 can bind the p53BSs in intron 1 of NDRG2 using the in vivo ChIP assay. As shown in Figure 4A, in Saos2 cells upon Ad-p53 infection and in A549 cells upon Adr treatment, the fragment (+889/+1082 bp) containing the p53BSs in NDRG2 intron 1 was amplified by PCR from DNA-protein complexes that were coimmunoprecipitated using the anti-p53 antibody. In contrast, a DNA sequence (-235/-62 bp) far from the p53BSs failed to be coimmunoprecipitated and amplified. Figure 4.p53 binds to the putative p53-binding site of NDRG2 intron 1 in vivo and in vitro. (A) Binding of exogenous or endogenous p53 to the p53-binding site in NDRG2 intron 1 in vivo by the ChIP assay. Cell lysates from Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (left, upper and lower panel) or from A549 cells that were pretreated with 0.4 mug/ml Adr or DMSO for 24 h (right, upper and lower panel) were prepared, cross-linked and immunoprecipitated in the presence or absence of p53-specific antibody. The immunoprecipitated samples were analyzed by PCR amplification using the primers flanking the p53BSs in NDRG2 intron 1 or the control region, as indicated in the Materials and methods section. Genomic DNA and input chromatin (input), which represent portions of sonicated chromatin before immunoprecipitation, were both used as positive controls. (B and C) Binding of exogenous or endogenous p53 to the p53-binding site in NDRG2 intron 1 in vitro was measured by EMSA. Nuclear extracts of Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (B) or of A549 cells that were pretreated with or without Adr for 24 h (C) were prepared and incubated with biotin-labeled wt or mutant probes for p53BSs in NDRG2 intron 1 [NDRG2-wt-p53BSs (lanes 3-9); NDRG2-mt-p53BSs (lanes 1 and 2)], or together with competitive unlabeled probes [NDRG2-wt-p53BSs (lanes 5 and 6); NDRG2-mt-p53BSs (lane 8)]. DNA-protein complexes were separated on a 6% TBE gel, transferred to nylon membranes and shifted probes were detected with HRP-conjugated streptavidin.
###end p 53
###begin p 54
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 84 85 84 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 625 630 624 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 869 870 868 869 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 875 876 874 875 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 944 949 943 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 959 967 958 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1230 1235 1229 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1246 1251 1245 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1275 1280 1274 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1356 1361 1355 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1389 1394 1388 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
p53 binds to the putative p53-binding site of NDRG2 intron 1 in vivo and in vitro. (A) Binding of exogenous or endogenous p53 to the p53-binding site in NDRG2 intron 1 in vivo by the ChIP assay. Cell lysates from Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (left, upper and lower panel) or from A549 cells that were pretreated with 0.4 mug/ml Adr or DMSO for 24 h (right, upper and lower panel) were prepared, cross-linked and immunoprecipitated in the presence or absence of p53-specific antibody. The immunoprecipitated samples were analyzed by PCR amplification using the primers flanking the p53BSs in NDRG2 intron 1 or the control region, as indicated in the Materials and methods section. Genomic DNA and input chromatin (input), which represent portions of sonicated chromatin before immunoprecipitation, were both used as positive controls. (B and C) Binding of exogenous or endogenous p53 to the p53-binding site in NDRG2 intron 1 in vitro was measured by EMSA. Nuclear extracts of Saos2 cells that were infected with Ad-p53 or Ad-LacZ for 48 h (B) or of A549 cells that were pretreated with or without Adr for 24 h (C) were prepared and incubated with biotin-labeled wt or mutant probes for p53BSs in NDRG2 intron 1 [NDRG2-wt-p53BSs (lanes 3-9); NDRG2-mt-p53BSs (lanes 1 and 2)], or together with competitive unlabeled probes [NDRG2-wt-p53BSs (lanes 5 and 6); NDRG2-mt-p53BSs (lane 8)]. DNA-protein complexes were separated on a 6% TBE gel, transferred to nylon membranes and shifted probes were detected with HRP-conjugated streptavidin.
###end p 54
###begin p 55
###xml 47 55 47 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 69 77 69 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 291 299 291 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 401 406 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 507 515 507 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 553 561 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 768 776 768 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 880 885 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Next, we used EMSA to confirm this interaction in vitro. As shown in Figure 4B and C, when the labeled wt probe for NDRG2-p53BSs was incubated with extracts from Ad-p53-infected Saos2 cells or Adr-treated A549 cells, we detected a clear band shift that did not occur with Ad-LacZ infection (Figure 4B, lane 4 versus 9) or vehicle treatment (Figure 4C, lane 4 versus 9). However, when using the mutant NDRG2-p53BSs probe, we did not observe band shifts with extracts from either Ad-p53-infected Saos2 cells (Figure 4B, lane 2) or Adr-treated A549 cells (Figure 4C, lane 2). The unlabeled wt NDRG2-p53BSs probe, rather than the mutant version, is able to reduce the protein-DNA complex formation in a dose-dependent manner when included in the reaction as a competitor (Figure 4B and C, lane 4 versus lanes 5 and 6; and lane 7 versus 8). Taken together, these results indicate that NDRG2 is a direct target gene of p53.
###end p 55
###begin title 56
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Silencing of NDRG2 inhibits p53-mediated apoptosis
###end title 56
###begin p 57
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 270 278 270 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 465 470 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 492 501 492 501 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5.</label>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 623 628 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 809 810 808 809 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 908 909 907 908 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 914 915 913 914 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1166 1167 1165 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 501 1175 501 1174 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">Silencing of <italic>NDRG2</italic> attenuates p53-mediated apoptosis. Saos2 and A549 cells were transfected with pSilencer-X or pSilencer-<italic>NDRG2</italic> and stable clones were generated. Stable clones were either infected with Ad-p53 or Ad-LacZ (mock) for 48 h (Saos2) or treated with 0.4 &#956;g/ml Adr or DMSO (mock) for 24 h (A549). (<bold>A</bold>) Western blot was performed using anti-Ndrg2, anti-p53 and anti-actin antibodies, respectively. (<bold>B</bold> and <bold>C</bold>) The apoptotic cells were analyzed by flow cytometry and quantified (B) or analyzed by the TUNEL assay (C). All the experiments were independently performed in triplicate. In (B), the histograms represent the average with error bars showing the SD. *<italic>P</italic> &lt; 0.05.</p>
###xml 501 1175 501 1174 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">Silencing of <italic>NDRG2</italic> attenuates p53-mediated apoptosis. Saos2 and A549 cells were transfected with pSilencer-X or pSilencer-<italic>NDRG2</italic> and stable clones were generated. Stable clones were either infected with Ad-p53 or Ad-LacZ (mock) for 48 h (Saos2) or treated with 0.4 &#956;g/ml Adr or DMSO (mock) for 24 h (A549). (<bold>A</bold>) Western blot was performed using anti-Ndrg2, anti-p53 and anti-actin antibodies, respectively. (<bold>B</bold> and <bold>C</bold>) The apoptotic cells were analyzed by flow cytometry and quantified (B) or analyzed by the TUNEL assay (C). All the experiments were independently performed in triplicate. In (B), the histograms represent the average with error bars showing the SD. *<italic>P</italic> &lt; 0.05.</p></caption>
###xml 1175 1175 1174 1174 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f5a"/>
###xml 1175 1175 1174 1174 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f5b"/>
###xml 492 1175 492 1174 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5.</label><caption><p textid="58">Silencing of <italic>NDRG2</italic> attenuates p53-mediated apoptosis. Saos2 and A549 cells were transfected with pSilencer-X or pSilencer-<italic>NDRG2</italic> and stable clones were generated. Stable clones were either infected with Ad-p53 or Ad-LacZ (mock) for 48 h (Saos2) or treated with 0.4 &#956;g/ml Adr or DMSO (mock) for 24 h (A549). (<bold>A</bold>) Western blot was performed using anti-Ndrg2, anti-p53 and anti-actin antibodies, respectively. (<bold>B</bold> and <bold>C</bold>) The apoptotic cells were analyzed by flow cytometry and quantified (B) or analyzed by the TUNEL assay (C). All the experiments were independently performed in triplicate. In (B), the histograms represent the average with error bars showing the SD. *<italic>P</italic> &lt; 0.05.</p></caption><graphic xlink:href="gkn504f5a"/><graphic xlink:href="gkn504f5b"/></fig>
To investigate the functional role of Ndrg2 in the p53-regulated pathway, Saos2 (p53 null) cells and A549 (wt-p53) were transfected with siRNA vectors that target NDRG2 (pSliencer-NDRG2) or control vectors (pSliencer-X) and stable cell clones were obtained. As shown in Figure 5A (left panel), the expression of Ndrg2 was amplified after p53 introduction (Saos2) or Adr treatment (A549) in the control cells, whereas such an effect was obviously compromised in the NDRG2-siRNA transfectants. Figure 5.Silencing of NDRG2 attenuates p53-mediated apoptosis. Saos2 and A549 cells were transfected with pSilencer-X or pSilencer-NDRG2 and stable clones were generated. Stable clones were either infected with Ad-p53 or Ad-LacZ (mock) for 48 h (Saos2) or treated with 0.4 mug/ml Adr or DMSO (mock) for 24 h (A549). (A) Western blot was performed using anti-Ndrg2, anti-p53 and anti-actin antibodies, respectively. (B and C) The apoptotic cells were analyzed by flow cytometry and quantified (B) or analyzed by the TUNEL assay (C). All the experiments were independently performed in triplicate. In (B), the histograms represent the average with error bars showing the SD. *P < 0.05.
###end p 57
###begin p 58
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 308 309 307 308 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 407 408 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 413 414 412 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 665 666 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Silencing of NDRG2 attenuates p53-mediated apoptosis. Saos2 and A549 cells were transfected with pSilencer-X or pSilencer-NDRG2 and stable clones were generated. Stable clones were either infected with Ad-p53 or Ad-LacZ (mock) for 48 h (Saos2) or treated with 0.4 mug/ml Adr or DMSO (mock) for 24 h (A549). (A) Western blot was performed using anti-Ndrg2, anti-p53 and anti-actin antibodies, respectively. (B and C) The apoptotic cells were analyzed by flow cytometry and quantified (B) or analyzed by the TUNEL assay (C). All the experiments were independently performed in triplicate. In (B), the histograms represent the average with error bars showing the SD. *P < 0.05.
###end p 58
###begin p 59
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 227 235 227 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 714 722 714 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 818 823 818 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 857 858 857 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 936 944 936 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 1047 1052 1047 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
To determine whether Ndrg2 contributed to p53-mediated apoptosis, we first examined the pro-apoptotic effect of p53 introduction in Saos2 cells, where NDRG2 expression was either knocked down or not. As shown in upper panel of Figure 5B, control cells transfected with pSilencer-X underwent extensive p53-triggered apoptosis, as indicated by the proportion of annexin V positive cells (74.8%). In contrast, the p53-inducecd apoptotic effects were greatly compromised by NDRG2 knockdown in pSilencer-NDRG2 transfected cells (44.2%). Next, we observed whether Ndrg2 knockdown also had an effect on the process of endogenous p53-mediated apoptosis in A549 cells that were treated with Adr. As shown in lower panel of Figure 5B, Adr treatment caused more apoptosis in the cells transfected with pSilencer-X than pSilencer-NDRG2 (72.1 + 5.3% versus 65.1 + 2.1%, P < 0.01). Finally, we confirmed these results by the TUNEL assay. As shown in Figure 5C, there are significantly more apoptotic cells in the pSilencer-X transfectants than in the pSilencer-NDRG2 transfectants following Ad-p53 infection in Saos2 cells/or Adr treatment in A549 cells. These data indicate that Ndrg2 is required for p53-mediated apoptosis.
###end p 59
###begin title 60
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Overexpression of NDRG2 suppresses tumor cell growth
###end title 60
###begin p 61
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 339 347 339 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 351 360 351 360 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 6.</label>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 422 423 422 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 528 533 528 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 760 761 760 761 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 867 868 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 946 947 946 947 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 360 1270 360 1266 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="62">Overexpression of <italic>NDRG2</italic> inhibits cell growth in Saos2 cells. (<bold>A</bold>) Saos2 cells were transfected with either empty vector [pcDNA3.1(+)] or the vector carrying Flag-tagged <italic>NDRG2</italic> and stable clones were generated. Western blot was performed using anti-Ndrg2, anti-Flag and anti-actin antibodies, respectively. pcDNA3.1(+)-F-2 and pcDNA3.1(+)-F-4 represent the two different clones that overexpress Ndrg2. (<bold>B</bold>) The stable Saos2 clones indicated in (A) were seeded into 96-well plates at a starting density of 1 &#215; 10<sup>3</sup> cells/well in triplicate, and growth curves were obtained by the MTT assay. (<bold>C</bold>) The stable Saos2 clones indicated in (A) were seeded into 6-cm dishes at a density of 200 cells/dish in triplicate and cultured in the presence of G418 (500 &#181;g/ml) for four weeks to allow colonies to develop. The colonies were fixed, stained with Coomassie blue and photographed (the representative dishes are shown).</p>
###xml 360 1270 360 1266 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="62">Overexpression of <italic>NDRG2</italic> inhibits cell growth in Saos2 cells. (<bold>A</bold>) Saos2 cells were transfected with either empty vector [pcDNA3.1(+)] or the vector carrying Flag-tagged <italic>NDRG2</italic> and stable clones were generated. Western blot was performed using anti-Ndrg2, anti-Flag and anti-actin antibodies, respectively. pcDNA3.1(+)-F-2 and pcDNA3.1(+)-F-4 represent the two different clones that overexpress Ndrg2. (<bold>B</bold>) The stable Saos2 clones indicated in (A) were seeded into 96-well plates at a starting density of 1 &#215; 10<sup>3</sup> cells/well in triplicate, and growth curves were obtained by the MTT assay. (<bold>C</bold>) The stable Saos2 clones indicated in (A) were seeded into 6-cm dishes at a density of 200 cells/dish in triplicate and cultured in the presence of G418 (500 &#181;g/ml) for four weeks to allow colonies to develop. The colonies were fixed, stained with Coomassie blue and photographed (the representative dishes are shown).</p></caption>
###xml 1270 1270 1266 1266 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="gkn504f6"/>
###xml 351 1270 351 1266 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F6" position="float"><label>Figure 6.</label><caption><p textid="62">Overexpression of <italic>NDRG2</italic> inhibits cell growth in Saos2 cells. (<bold>A</bold>) Saos2 cells were transfected with either empty vector [pcDNA3.1(+)] or the vector carrying Flag-tagged <italic>NDRG2</italic> and stable clones were generated. Western blot was performed using anti-Ndrg2, anti-Flag and anti-actin antibodies, respectively. pcDNA3.1(+)-F-2 and pcDNA3.1(+)-F-4 represent the two different clones that overexpress Ndrg2. (<bold>B</bold>) The stable Saos2 clones indicated in (A) were seeded into 96-well plates at a starting density of 1 &#215; 10<sup>3</sup> cells/well in triplicate, and growth curves were obtained by the MTT assay. (<bold>C</bold>) The stable Saos2 clones indicated in (A) were seeded into 6-cm dishes at a density of 200 cells/dish in triplicate and cultured in the presence of G418 (500 &#181;g/ml) for four weeks to allow colonies to develop. The colonies were fixed, stained with Coomassie blue and photographed (the representative dishes are shown).</p></caption><graphic xlink:href="gkn504f6"/></fig>
To further evaluate the biological role of Ndrg2 in tumor cells, we generated two Saos2 cell lines that were stably transfected with pcDNA3.1(+)-Flag-NDRG2 [pcDNA3.1(+)-F-2 and pcDNA3.1(+)-F-4], and stable empty vector-transfected clones [pcDNA3.1(+)] were used as the control. Ndrg2 overexpression was confirmed by western blot analysis (Figure 6A). Figure 6.Overexpression of NDRG2 inhibits cell growth in Saos2 cells. (A) Saos2 cells were transfected with either empty vector [pcDNA3.1(+)] or the vector carrying Flag-tagged NDRG2 and stable clones were generated. Western blot was performed using anti-Ndrg2, anti-Flag and anti-actin antibodies, respectively. pcDNA3.1(+)-F-2 and pcDNA3.1(+)-F-4 represent the two different clones that overexpress Ndrg2. (B) The stable Saos2 clones indicated in (A) were seeded into 96-well plates at a starting density of 1 x 103 cells/well in triplicate, and growth curves were obtained by the MTT assay. (C) The stable Saos2 clones indicated in (A) were seeded into 6-cm dishes at a density of 200 cells/dish in triplicate and cultured in the presence of G418 (500 microg/ml) for four weeks to allow colonies to develop. The colonies were fixed, stained with Coomassie blue and photographed (the representative dishes are shown).
###end p 61
###begin p 62
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 62 63 62 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 400 401 400 401 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 507 508 507 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 586 587 586 587 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Overexpression of NDRG2 inhibits cell growth in Saos2 cells. (A) Saos2 cells were transfected with either empty vector [pcDNA3.1(+)] or the vector carrying Flag-tagged NDRG2 and stable clones were generated. Western blot was performed using anti-Ndrg2, anti-Flag and anti-actin antibodies, respectively. pcDNA3.1(+)-F-2 and pcDNA3.1(+)-F-4 represent the two different clones that overexpress Ndrg2. (B) The stable Saos2 clones indicated in (A) were seeded into 96-well plates at a starting density of 1 x 103 cells/well in triplicate, and growth curves were obtained by the MTT assay. (C) The stable Saos2 clones indicated in (A) were seeded into 6-cm dishes at a density of 200 cells/dish in triplicate and cultured in the presence of G418 (500 microg/ml) for four weeks to allow colonies to develop. The colonies were fixed, stained with Coomassie blue and photographed (the representative dishes are shown).
###end p 62
###begin p 63
###xml 86 94 86 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 388 396 388 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
To determine whether Ndrg2 has any effect on cell growth, we performed the MTT assay (Figure 6B). The results demonstrated that enhanced expression of Ndrg2 inhibited cell growth in comparison to the control, implying that Ndrg2 may play an inhibitory role in cell proliferation. We then performed colony formation assays to evaluate the proliferating ability of these cells. As shown in Figure 6C, overexpressed Ndrg2 significantly inhibited the colony-forming ability of Saos2 cells, consistent with the results of the MTT assay.
###end p 63
###begin p 64
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Considering that stable clones generated by selective pressure may differ from their parental cells, we also transiently transfected pcDNA3.1(+)-Flag-NDRG2 into Saos2 cells and observe its effect on cell growth and apoptosis. The results showed that enhanced expression of Ndrg2 inhibits cell growth in comparison to the control (Figure S1B). However, Ndrg2 overexpression does not promote cell apoptosis (Figure S1C), implying that Ndrg2 suppresses cell growth through inhibiting proliferation rather than inducing apoptosis.
###end p 64
###begin p 65
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
To further examine whether Ndrg2 has an antiproliferation effect on wt p53-bearing tumor cells, we infected A549 cells with Ad-NDRG2 or Ad-LacZ and found that Ndrg2 overexpression suppressed the growth of A549 cells using the MTT assay (data not shown). Collectively, these data suggest that Ndrg2 is involved in suppression of cell proliferation, regardless of the presence or absence of p53.
###end p 65
###begin title 66
DISCUSSION
###end title 66
###begin p 67
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 607 612 607 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21 B22 B23">21&#8211;23</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 616 621 616 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50 B51 B52 B53 B54">50&#8211;54</xref>
###xml 783 788 783 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55 B56 B57">55&#8211;57</xref>
###xml 855 856 855 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 857 858 857 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1017 1022 1017 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
As one of the most commonly altered genes in human cancer, research on p53 has been intense for many years. It is well established that most of the biological effects of p53 are due to its function as a transcription factor. Although a variety of p53 downstream target genes have been identified, which are involved in apoptosis (e.g. BAX, DR5, BID, APAF-1, Caspase-6, PIGs, Perp, p53AIP, SCN3B and Scotin), knockout of any one individual gene has failed to protect cells completely from p53-induced death. These findings suggest that the p53 response requires a network of collaborating genes (10,13,17,19,21-23,25,50-54). In addition, several studies have shown that some genes with antiapoptotic activity, such as HB-EGF, DcR1 and DcR2, can be transcriptionally activated by p53 (55-57), while others, such as survivin and PTGG1, are repressed by p53 (6,7). Thus, the p53 pathway is complicated, and identification of additional p53 targets is critical for understanding the pathway. Here, our results reveal that NDRG2 is a p53-inducible target gene that is transactivated by p53 and is involved in p53-mediated apoptosis.
###end p 67
###begin p 68
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG</italic>
###xml 626 631 626 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Increased NDRG2 mRNA and protein levels occurred not only after treatment with the DNA-damaging agents or stress, which activates endogenous p53, but also following adenovirus-mediated ectopic expression of p53 in p53 null cells. Neither DNA damage in p53 mutant and p53 null cell lines nor introduction of mutant p53 could enhance NDRG2 expression; moreover, knockdown of endogenous p53 markedly attenuated Adr-induced increase of Ndrg2, indicating that the effect requires intact p53. Considering the previous finding that NDRG1, a member of NDRG family, is a direct transcriptional target gene of p53, we hypothesized that NDRG2 could also be a p53 target gene.
###end p 68
###begin p 69
###xml 6 11 6 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG1</italic>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
While NDRG1 has a p53 responsive element in its promoter, we identified one candidate sequence for p53BSs within intron 1 of NDRG2. The NDRG2 element contained all the conserved residues, as well as five mismatches, of the consensus p53BS. It is well documented that p53 target genes harbor p53BSs in either their promoters or intronic regions, and sequences with different mismatched bases may vary considerably in their transactivation function (52,58). Interestingly, some response elements whose structures are quite different from the canonical p53 consensus site can also be recognized by p53 (52).
###end p 69
###begin p 70
###xml 59 64 59 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 508 513 508 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 839 844 839 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDGR2</italic>
Our experiments demonstrate that the putative p53BS within NDRG2 intron is a functional one in response to exogenous or endogenous wt p53, as shown in reporter assays. Reporter constructs carrying the endogenous NDRG2 promoter region, exon 1 and intron 1 containing p53BSs exhibited increased transcriptional activity upon p53 activation. Meanwhile, the corresponding counterpart lacking p53BSs showed no response to p53, indicating that the intronic p53BSs are essential for p53-mediated transactivation of NDRG2. Using ChIP and EMSA, we demonstrated that the p53BSs form protein-DNA complexes in Ad-p53-infected p53 null cells or Adr-treated wt p53-bearing cells, suggesting that the intronic NDRG2 p53BSs can bind to p53 after its activation and DNA damage. Collectively, we provide compelling evidence that p53 directly transactivates NDGR2 via intronic p53BSs.
###end p 70
###begin p 71
###xml 19 23 19 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 490 495 490 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46 B47 B48">46&#8211;48</xref>
###xml 535 540 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 804 809 804 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46 B47 B48">46&#8211;48</xref>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 948 953 948 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1096 1098 1096 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1099 1101 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1482 1483 1482 1483 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1597 1599 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1622 1628 1622 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1630 1632 1630 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1652 1657 1652 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 1284 1289 <span type="species:ncbi:9606">human</span>
As a member of the NDRG family, the NDRG2 gene has been mapped to chromosome 14q11.2, and encodes a 41 kDa protein, which is expressed in various tissues, particularly in the brain, heart and skeletal muscle (28). Although the precise function of Ndrg2 is still unclear, it has been shown to be intimately involved in numerous biological processes, such as cell differentiation (30,35,38), neurodegeneration (39), stress responses (34), as well as carcinogenesis and cancer progression (44,46-48). Mounting evidence has indicated that NDRG2 mRNA levels are downregulated or undetectable in a number of human cancers and cancer cell-lines, including glioblastoma, squamous cell carcinoma, pancreatic cancer, gastric cancer and colorectal carcinoma, compared to their cognate noncancerous counterparts (44,46-48). Moreover, NDRG2 expression has been inversely correlated with tumor grade and aggressive tumor behavior (43,45). In two recent reports, NDRG2 was even identified as a gene whose expression in high-grade primary astrocytomas or gastric cancers was positively correlated with survival (47,48). These findings strongly implicate Ndrg2 is a tumor suppressor. However, to date, only a few studies have explored the role of Ndrg2 in tumor suppression. Ndrg2 overexpression in a human glioblastoma cell line was shown to markedly inhibit cell proliferation (43). Another study from our laboratory demonstrated that Ndrg2 translocates from the cytosol into the nucleus upon NiCl2 treatment, where it interacts with the MSP58 oncoprotein and inhibits MSP58-induced proliferation of HeLa cells (59). Most recently, Choi et al. (47) demonstrated that NDRG2 silencing can decrease Fas-mediated cell death via a slight downregulation of Fas expression in SNU-620 gastric cancer cell lines.
###end p 71
###begin p 72
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 349 354 349 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 822 827 822 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17 B18 B19">17&#8211;19</xref>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1300 1302 1300 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1684 1689 1684 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1830 1832 1830 1832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1883 1885 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 1915 1920 1915 1920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 1988 1993 1988 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
Here, we showed that Ndrg2 is required for the full p53-mediated apoptotic response. Additionally, we showed that NDRG2 knockdown using siRNA markedly attenuated the p53-mediated apoptotic effect. It is possible that the attenuation was incomplete because the silencing efficiency in our current experiment was not high enough to entirely block the NDRG2 expression. Alternatively, it is likely that other apoptosis-related proteins that are downstream of p53 play a compensatory role in the case of NDRG2 knockdown by contributing to the apoptotic effect. In this regard, the function of Ndrg2 may be similar to many known p53 targets, such as BAX, BID, CD95, APAF-1 and DR5, since when each of these genes is silenced or removed from a particular model system, a partial resistance to p53-induced apoptosis is observed (17-19,21,25,54). Therefore, our results together with two recent reports (23,34) support the idea that p53-dependent apoptosis is a complex process, reflecting the combined effect of a number of p53-inducible targets. As for the role of Ndrg2 in the p53-initiated apoptosis pathway, it is unlikely that Ndrg2 functions as a pro-apoptotic factor because we did not observed Ndrg2-promoted apoptosis following its overexpression in p53-null Saos2 cells and p53-intact A549 cells (34). Another possibility is that Ndrg2 may play a regulatory role either by facilitating apoptosis choice over cell-cycle arrest for p53 in response to stresses, or by regulating p53 downstream targets that are implicated directly in apoptosis, such as Bax, PUMA and NOXA. Further studies are needed to prove or disprove these hypotheses. Interestingly, our previous data showed that NDRG2 also participates in hypoxia-evoked apoptotic response in A549 cells at least partially by acting as a hypoxia-inducible HIF-1 target gene (34), provided that hypoxia-induced p53 accumulation (60) and subsequent induction of NDRG2 may play a role during this process. Collectively, it appears that NDRG2 can act as a stress-responsive gene to facilitate cell death in order to eliminate hazardous cells.
###end p 72
###begin p 73
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
We have also shown that NDRG2 overexpression led to inhibition of cell proliferation, regardless of the absence or presence of p53, which is consistent with previous reports (43,59). These results suggest that Ndrg2 has an inhibitory role on proliferation that might be p53 independent. Nevertheless, in case of p53-intact cells, whether the proliferation-inhibitory role of Ndrg2 influences its positive role in apoptosis and vice versa still remains to be determined.
###end p 73
###begin p 74
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NDRG2</italic>
In summary, this study demonstrated for the first time that NDRG2, a novel p53-inducible gene, is implicated in the p53-mediated apoptosis pathway in response to DNA damage and also plays a proliferation-inhibitory role that is independent of p53 status. These findings contribute insights for the function of Ndrg2, particularly its stress-responsive activity and tumor-repressive effects.
###end p 74
###begin title 75
SUPPLEMENTARY DATA
###end title 75
###begin p 76
 are available at NAR Online.
###end p 76
###begin title 77
Supplementary Material
###end title 77
###begin title 78
[Supplementary Data]
###end title 78
###begin title 79
ACKNOWLEDGEMENTS
###end title 79
###begin p 80
This work was supported in part by grants from The National High Technology Research and Development Program of China (2006AA02Z194), the Program for Changjiang Scholars and Innovative Research Team in University (IRT0459) and the National Natural Science Foundation of China (30370315, 30570676). Funding to pay the Open Access publication charges for this article was provided by The National High Technology Research and Development Program of China (2006AA02Z194).
###end p 80
###begin p 81
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 81
###begin title 82
REFERENCES
###end title 82
###begin article-title 83
Live or let die: the cell's response to p53
###end article-title 83
###begin article-title 84
Surfing the p53 network
###end article-title 84
###begin article-title 85
Control of apoptosis by p53
###end article-title 85
###begin article-title 86
The transcriptional targets of p53 in apoptosis control
###end article-title 86
###begin article-title 87
Dissecting p53 tumor suppressor functions in vivo
###end article-title 87
###begin article-title 88
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53
###end article-title 88
###begin article-title 89
p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis
###end article-title 89
###begin article-title 90
Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation
###end article-title 90
###begin article-title 91
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function
###end article-title 91
###begin article-title 92
Complicating the complexity of p53
###end article-title 92
###begin article-title 93
MDM2 is a central node in the p53 pathway: 12 years and counting
###end article-title 93
###begin article-title 94
Gene-specific mechanisms of p53 transcriptional control and prospects for cancer therapy
###end article-title 94
###begin article-title 95
The complexity of p53 modulation: emerging patterns from divergent signals
###end article-title 95
###begin article-title 96
Definition of a consensus binding site for p53
###end article-title 96
###begin article-title 97
Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis
###end article-title 97
###begin article-title 98
PUMA, a novel proapoptotic gene, is induced by p53
###end article-title 98
###begin article-title 99
###xml 66 71 <span type="species:ncbi:9606">human</span>
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
###end article-title 99
###begin article-title 100
p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
###end article-title 100
###begin article-title 101
BID regulation by p53 contributes to chemosensitivity
###end article-title 101
###begin article-title 102
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis
###end article-title 102
###begin article-title 103
KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
###end article-title 103
###begin article-title 104
Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane
###end article-title 104
###begin article-title 105
Identification of SCN3B as a novel p53-inducible proapoptotic gene
###end article-title 105
###begin article-title 106
NDRG1 is necessary for p53-dependent apoptosis
###end article-title 106
###begin article-title 107
Dissecting p53-dependent apoptosis
###end article-title 107
###begin article-title 108
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 84 91 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Exploring a new gene containing ACP like domain in human brain and expression it in E. coli
###end article-title 108
###begin article-title 109
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart
###end article-title 109
###begin article-title 110
###xml 91 96 <span type="species:ncbi:9606">human</span>
Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family
###end article-title 110
###begin article-title 111
Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc
###end article-title 111
###begin article-title 112
###xml 18 23 <span type="species:ncbi:9606">human</span>
The repression of human differentiation-related gene NDRG2 expression by Myc via Miz-1-dependent interaction with the NDRG2 core promoter
###end article-title 112
###begin article-title 113
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant
###end article-title 113
###begin article-title 114
Cap43, a novel gene specifically induced by Ni2+ compounds
###end article-title 114
###begin article-title 115
###xml 59 64 <span type="species:ncbi:9606">human</span>
N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury
###end article-title 115
###begin article-title 116
NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells
###end article-title 116
###begin article-title 117
Ndrg2 promotes neurite outgrowth of NGF-differentiated PC12 cells
###end article-title 117
###begin article-title 118
Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer
###end article-title 118
###begin article-title 119
NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states
###end article-title 119
###begin article-title 120
Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells
###end article-title 120
###begin article-title 121
NDRG2: a novel Alzheimer's disease associated protein
###end article-title 121
###begin article-title 122
N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom
###end article-title 122
###begin article-title 123
Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression
###end article-title 123
###begin article-title 124
The Drg-1 gene suppresses tumor metastasis in prostate cancer
###end article-title 124
###begin article-title 125
N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation
###end article-title 125
###begin article-title 126
###xml 33 38 <span type="species:ncbi:9606">human</span>
NDRG2 expression and mutation in human liver and pancreatic cancers
###end article-title 126
###begin article-title 127
Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma
###end article-title 127
###begin article-title 128
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
###end article-title 128
###begin article-title 129
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death
###end article-title 129
###begin article-title 130
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
###end article-title 130
###begin article-title 131
DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways
###end article-title 131
###begin article-title 132
Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling
###end article-title 132
###begin article-title 133
p53-dependent pathways of apoptosis
###end article-title 133
###begin article-title 134
The P53 pathway: what questions remain to be explored?
###end article-title 134
###begin article-title 135
Apoptotic threshold is lowered by p53 transactivation of caspase-6
###end article-title 135
###begin article-title 136
Apaf-1 is a transcriptional target for E2F and p53
###end article-title 136
###begin article-title 137
p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades
###end article-title 137
###begin article-title 138
Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity
###end article-title 138
###begin article-title 139
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site
###end article-title 139
###begin article-title 140
###xml 83 89 <span type="species:ncbi:9606">humans</span>
Functional diversity in the gene network controlled by the master regulator p53 in humans
###end article-title 140
###begin article-title 141
The physical and functional interaction of NDRG2 with MSP58 in cells
###end article-title 141
###begin article-title 142
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status
###end article-title 142

